| Year |
Citation |
Score |
| 2023 |
Alsulami K, Dupuy FP, Gilbert L, Messier-Peet M, Durand M, Tremblay C, Routy JP, Bruneau J, Baril JG, Trottier B, Bernard NF. The Frequency and Function of NKG2CCD57 Adaptive NK Cells in Cytomagalovirus Co-Infected People Living with HIV Decline with Duration of Antiretroviral Therapy. Viruses. 15. PMID 36851537 DOI: 10.3390/v15020323 |
0.362 |
|
| 2022 |
Bellini N, Lodge R, Pham TNQ, Jain J, Murooka TT, Herschhorn A, Bernard NF, Routy JP, Tremblay CL, Cohen ÉA. MiRNA-103 downmodulates CCR5 expression reducing human immunodeficiency virus type-1 entry and impacting latency establishment in CD4 T cells. Iscience. 25: 105234. PMID 36267915 DOI: 10.1016/j.isci.2022.105234 |
0.387 |
|
| 2022 |
Alsulami K, Sadouni M, Tremblay-Sher D, Baril JG, Trottier B, Dupuy FP, Chartrand-Lefebvre C, Tremblay C, Durand M, Bernard NF. High frequencies of adaptive NK cells are associated with absence of coronary plaque in cytomegalovirus infected people living with HIV. Medicine. 101: e30794. PMID 36197157 DOI: 10.1097/MD.0000000000030794 |
0.371 |
|
| 2022 |
Kant S, Dupuy FP, Kiani Z, Tremblay CL, Bernard NF. Contribution of Natural Killer cells to HIV control in Elite Controllers. Virologie (Montrouge, France). 26: 34-49. PMID 35766089 DOI: 10.1684/vir.2022.0933 |
0.546 |
|
| 2022 |
Bernard NF, Alsulami K, Pavey E, Dupuy FP. NK Cells in Protection from HIV Infection. Viruses. 14. PMID 35746615 DOI: 10.3390/v14061143 |
0.531 |
|
| 2022 |
Bernard NF, Kant S, Kiani Z, Tremblay C, Dupuy FP. Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control. Frontiers in Immunology. 13: 879124. PMID 35720328 DOI: 10.3389/fimmu.2022.879124 |
0.54 |
|
| 2022 |
Isnard S, Royston L, Lin J, Fombuena B, Bu S, Kant S, Mabanga T, Berini C, El-Far M, Durand M, Tremblay CL, Bernard NF, Kroemer G, Routy JP. Distinct Plasma Concentrations of Acyl-CoA-Binding Protein (ACBP) in HIV Progressors and Elite Controllers. Viruses. 14. PMID 35336860 DOI: 10.3390/v14030453 |
0.444 |
|
| 2021 |
Nagel L, Kant S, Leeks C, Routy JP, Tremblay C, Thomas R, Szabo J, Côté P, Trottier B, LeBlanc R, Rouleau D, Dupuy FP, Bernard NF. Evolution of antibodies to native trimeric envelope and their Fc dependent functions in untreated and treated primary HIV infection. Journal of Virology. JVI0162521. PMID 34586863 DOI: 10.1128/JVI.01625-21 |
0.384 |
|
| 2021 |
Bunet R, Nayrac M, Ramani H, Sylla M, Durand M, Chartrand-Lefebvre C, Routy JP, Landay AL, Gauchat JF, Chomont N, Ancuta P, Kaufmann DE, Bernard N, Tremblay CL, El-Far M. Loss of CD96 Expression as a Marker of HIV-Specific CD8 T-Cell Differentiation and Dysfunction. Frontiers in Immunology. 12: 673061. PMID 34122431 DOI: 10.3389/fimmu.2021.673061 |
0.351 |
|
| 2021 |
Alsulami K, Bolastig N, Dupuy FP, Mabanga T, Gilbert L, Kiani Z, Routy JP, Bruneau J, Thomas R, Tremblay C, Tsoukas CM, Szabo J, Côté P, Trottier B, LeBlanc R, ... ... Bernard NF, et al. Influence of NKG2C Genotypes on HIV Susceptibility and Viral Load Set Point. Journal of Virology. JVI0041721. PMID 34076484 DOI: 10.1128/JVI.00417-21 |
0.474 |
|
| 2020 |
Meziane O, Alexandrova Y, Olivenstein R, Dupuy FP, Salahuddin S, Thomson E, Orlova M, Schurr E, Ancuta P, Durand M, Chomont N, Estaquier J, Bernard NF, Costiniuk CT, Jenabian MA. Peculiar Phenotypic and Cytotoxic Features of Pulmonary Mucosal CD8 T Cells in People Living with HIV Receiving Long-Term Antiretroviral Therapy. Journal of Immunology (Baltimore, Md. : 1950). PMID 33318292 DOI: 10.4049/jimmunol.2000916 |
0.414 |
|
| 2020 |
Kant S, Zhang N, Barbé A, Routy JP, Tremblay C, Thomas R, Szabo J, Côté P, Trottier B, LeBlanc R, Rouleau D, Harris M, Dupuy FP, Bernard NF. Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers. Frontiers in Immunology. 11: 583820. PMID 33101312 DOI: 10.3389/fimmu.2020.583820 |
0.502 |
|
| 2020 |
Isnard S, Ramendra R, Lin J, Kant S, Fombuena B, Ouyang J, Peng X, El Far M, Tremblay C, Bernard NF, Routy JP. Anti-CMV IgG is linked to CD4 T-cell count decay in HIV elite controllers. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32756974 DOI: 10.1093/Cid/Ciaa1129 |
0.526 |
|
| 2020 |
Niessl J, Baxter AE, Morou A, Brunet-Ratnasingham E, Sannier G, Gendron-Lepage G, Richard J, Delgado GG, Brassard N, Turcotte I, Fromentin R, Bernard NF, Chomont N, Routy JP, Dubé M, et al. Persistent expansion and Th1-like skewing of HIV-specific circulating T follicular helper cells during antiretroviral therapy. Ebiomedicine. 54: 102727. PMID 32268275 DOI: 10.1016/J.Ebiom.2020.102727 |
0.568 |
|
| 2019 |
Dupuy FP, Kant S, Barbé A, Routy JP, Bruneau J, Lebouché B, Tremblay C, Pazgier M, Finzi A, Bernard NF. Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects. Mbio. 10. PMID 31848282 DOI: 10.1128/Mbio.02690-19 |
0.604 |
|
| 2019 |
Kiani Z, Dupuy FP, Bruneau J, Lebouché B, Retière C, Geraghty DE, Bernard NF. The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells. Journal of Virology. PMID 31511383 DOI: 10.1128/Jvi.01185-19 |
0.578 |
|
| 2019 |
Isnard S, Ramendra R, Dupuy FP, Lin J, Fombuena B, Kokinov N, Kema I, Jenabian MA, Lebouché B, Costiniuk CT, Ancuta P, Bernard NF, Silverman MS, Lakatos PL, Durand M, et al. Plasma levels of C-type lectin REG3α and gut damage in people with HIV. The Journal of Infectious Diseases. PMID 31504638 DOI: 10.1093/Infdis/Jiz423 |
0.439 |
|
| 2019 |
Kiani Z, Bruneau J, Geraghty DE, Bernard NF. HLA-F on autologous HIV infected cells activates primary NK cells expressing the activating killer immunoglobulin-like receptor KIR3DS1. Journal of Virology. PMID 31270222 DOI: 10.1128/Jvi.00933-19 |
0.606 |
|
| 2019 |
Kant S, Zhang N, Routy JP, Tremblay C, Thomas R, Szabo J, Côté P, Trottier B, LeBlanc R, Rouleau D, Harris M, Dupuy FP, Bernard NF. Quantifying Anti-HIV Envelope-Specific Antibodies in Plasma from HIV Infected Individuals. Viruses. 11. PMID 31141927 DOI: 10.3390/V11060487 |
0.567 |
|
| 2019 |
Mehraj V, Ramendra R, Isnard S, Dupuy FP, Ponte R, Chen J, Kema I, Jenabian MA, Costiniuk C, Lebouché B, Thomas R, Coté P, Leblanc R, Baril JG, Durand M, ... ... Bernard NF, et al. Circulating (1→3)-β-D-Glucan is associated with immune activation during HIV infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30877304 DOI: 10.1093/Cid/Ciz212 |
0.505 |
|
| 2019 |
Lisovsky I, Kant S, Tremblay-McLean A, Isitman G, Kiani Z, Dupuy FP, Gilbert L, Bruneau J, Shoukry NH, Lebouché B, Bernard NF. Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody-dependent (AD) NK cell activation and ADCC. Journal of Leukocyte Biology. PMID 30698860 DOI: 10.1002/Jlb.4A0617-242Rrr |
0.404 |
|
| 2019 |
Tremblay-McLean A, Coenraads S, Kiani Z, Dupuy FP, Bernard NF. Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function. Bmc Immunology. 20: 8. PMID 30696399 DOI: 10.1186/S12865-018-0272-X |
0.36 |
|
| 2019 |
Isnard S, Ramendra R, Dupuy FP, Mehraj V, Lin J, Kokinov N, Lebouché B, Costiniuk C, Ancuta P, Bernard NF, Durand M, Tremblay C, Routy J-. Relevance of Reg3α and I-FABP on microbial translocation, inflammation and reservoir size in people living with HIV Journal of Virus Eradication. 5: 6. DOI: 10.1016/S2055-6640(20)31030-X |
0.468 |
|
| 2018 |
Kiani Z, Dupuy FP, Bruneau J, Lebouché B, Zhang CX, Jackson E, Lisovsky I, da Fonseca S, Geraghty DE, Bernard NF. HLA-F on HLA-Null 721.221 Cells Activates Primary NK Cells Expressing the Activating Killer Ig-like Receptor KIR3DS1. Journal of Immunology (Baltimore, Md. : 1950). PMID 29743316 DOI: 10.4049/Jimmunol.1701370 |
0.412 |
|
| 2018 |
Mehraj V, Ramendra R, Costiniuk C, Lebouché B, Ponte R, Thomas R, Szabo J, Coté P, Leblanc R, Baril J, Tremblay C, Bernard N, Sheppard DC, Routy J. Fungal microbial translocation changes during treated acute and chronic HIV infection Journal of Virus Eradication. 4: 7-8. DOI: 10.1016/S2055-6640(20)30369-1 |
0.479 |
|
| 2017 |
Luo M, Czarnecki C, Nebroski M, Kimani J, Bernard N, Plummer FA. KIR3DL1 alleles and their Epistatic Interactions with HLA Class I Influence Resistance and Susceptibility to HIV-1 acquisition in the Pumwani Sex Worker cohort. Aids (London, England). PMID 29280757 DOI: 10.1097/QAD.0000000000001735 |
0.327 |
|
| 2017 |
Wang C, Edilova MI, Wagar LE, Mujib S, Singer M, Bernard NF, Croughs T, Lederman MM, Sereti I, Fischl MA, Kremmer E, Ostrowski M, Routy JP, Watts TH. Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy. Journal of Immunology (Baltimore, Md. : 1950). PMID 29222166 DOI: 10.4049/Jimmunol.1601254 |
0.499 |
|
| 2017 |
Ponte R, Dupuy FP, Brimo F, Mehraj V, Brassard P, Belanger M, Yurchenko E, Jenabian MA, Bernard NF, Routy JP. Characterization of myeloid cell populations in human testes collected after sex reassignment surgery. Journal of Reproductive Immunology. 125: 16-24. PMID 29136520 DOI: 10.1016/J.Jri.2017.10.043 |
0.371 |
|
| 2017 |
Tremblay-McLean A, Bruneau J, Lebouché B, Lisovsky I, Song R, Bernard NF. Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4⁺ T Cells. Viruses. 9. PMID 29023371 DOI: 10.3390/V9100295 |
0.542 |
|
| 2017 |
Jackson E, Zhang CX, Kiani Z, Lisovsky I, Tallon B, Del Corpo A, Gilbert L, Bruneau J, Thomas R, Côté P, Trottier B, LeBlanc R, Rouleau D, Tremblay C, Tsoukas CM, ... ... Bernard NF, et al. HIV exposed seronegative (HESN) compared to HIV infected individuals have higher frequencies of telomeric Killer Immunoglobulin-like Receptor (KIR) B motifs; Contribution of KIR B motif encoded genes to NK cell responsiveness. Plos One. 12: e0185160. PMID 28938026 DOI: 10.1371/Journal.Pone.0185160 |
0.566 |
|
| 2017 |
Bernard NF. Natural killer (NK) cell receptor-HLA ligand genotype combinations associated with protection from HIV infection: investigation of how protective genotypes influence anti HIV NK cell functions. Aids Research and Therapy. 14: 38. PMID 28893287 DOI: 10.1186/S12981-017-0172-9 |
0.614 |
|
| 2017 |
Durand M, Chartrand-Lefebvre C, Baril JG, Trottier S, Trottier B, Harris M, Walmsley S, Conway B, Wong A, Routy JP, Kovacs C, MacPherson PA, Monteith KM, Mansour S, Thanassoulis G, ... ... Bernard N, et al. The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol. Bmc Infectious Diseases. 17: 611. PMID 28893184 DOI: 10.1186/S12879-017-2692-2 |
0.54 |
|
| 2017 |
Bernard NF, Kiani Z, Tremblay-McLean A, Kant SA, Leeks CE, Dupuy FP. Natural Killer (NK) Cell Education Differentially Influences HIV Antibody-Dependent NK Cell Activation and Antibody-Dependent Cellular Cytotoxicity. Frontiers in Immunology. 8: 1033. PMID 28883824 DOI: 10.3389/Fimmu.2017.01033 |
0.572 |
|
| 2017 |
Lewis GK, Pazgier M, Evans D, Ferrari G, Bournazos S, Parsons MS, Bernard NF, Finzi A. Beyond Viral Neutralization. Aids Research and Human Retroviruses. PMID 28084796 DOI: 10.1089/AID.2016.0299 |
0.393 |
|
| 2016 |
Boisvert M, Zhang W, Elrod EJ, Bernard NF, Villeneuve JP, Bruneau J, Marcotrigiano J, Shoukry NH, Grakoui A. Novel E2 Glycoprotein Tetramer Detects Hepatitis C Virus-Specific Memory B Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 27849172 DOI: 10.4049/Jimmunol.1600763 |
0.337 |
|
| 2016 |
Isitman G, Tremblay-McLean A, Lisovsky I, Bruneau J, Lebouché B, Routy JP, Bernard NF. NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts. Plos One. 11: e0164517. PMID 27732638 DOI: 10.1371/Journal.Pone.0164517 |
0.391 |
|
| 2016 |
Lisovsky I, Isitman G, Tremblay-McLean A, Song R, DaFonnseca S, Lebouchẻ B, Routy JP, Bruneau J, Bernard NF. The differential impact of NK cell education via KIR2DL3 and KIR3DL1 on CCL4 secretion in the context of in vitro HIV infection. Clinical and Experimental Immunology. PMID 27506421 DOI: 10.1111/Cei.12849 |
0.58 |
|
| 2016 |
Isitman G, Lisovsky I, Tremblay-McLean A, Kovacs C, Harris M, Routy JP, Bruneau J, Wainberg MA, Tremblay C, Bernard NF. Antibody dependent cellular cytotoxicity activity of effector cells from HIV infected Elite and Viral Controllers. Aids Research and Human Retroviruses. PMID 27499379 DOI: 10.1089/Aid.2016.0157 |
0.598 |
|
| 2016 |
Demers KR, Makedonas G, Buggert M, Eller MA, Ratcliffe SJ, Goonetilleke N, Li CK, Eller LA, Rono K, Maganga L, Nitayaphan S, Kibuuka H, Routy JP, Slifka MK, Haynes BF, ... ... Bernard NF, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. Plos Pathogens. 12: e1005805. PMID 27486665 DOI: 10.1371/Journal.Ppat.1005805 |
0.569 |
|
| 2016 |
El-Far M, Kouassi P, Sylla M, Zhang Y, Fouda A, Fabre T, Goulet JP, van Grevenynghe J, Lee T, Singer J, Harris M, Baril JG, Trottier B, Ancuta P, Routy JP, ... Bernard N, et al. Proinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors. Scientific Reports. 6: 22902. PMID 26978598 DOI: 10.1038/Srep22902 |
0.481 |
|
| 2015 |
Isitman G, Lisovsky I, Tremblay-McLean A, Parsons MS, Shoukry NH, Wainberg MA, Bruneau J, Bernard NF. Natural killer cell education does not affect the magnitude of granzyme B delivery to target cells by antibody-dependent cellular cytotoxicity. Aids (London, England). 29: 1433-43. PMID 26244383 DOI: 10.1097/Qad.0000000000000729 |
0.484 |
|
| 2015 |
Lisovsky I, Isitman G, Song R, DaFonseca S, Tremblay-McLean A, Lebouché B, Routy JP, Bruneau J, Bernard NF. A Higher Frequency of NKG2A+ than of NKG2A- NK Cells Responds to Autologous HIV-Infected CD4 Cells irrespective of Whether or Not They Coexpress KIR3DL1. Journal of Virology. 89: 9909-19. PMID 26202228 DOI: 10.1128/Jvi.01546-15 |
0.529 |
|
| 2015 |
DaFonseca S, Niessl J, Pouvreau S, Wacleche VS, Gosselin A, Cleret-Buhot A, Bernard N, Tremblay C, Jenabian MA, Routy JP, Ancuta P. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. Retrovirology. 12: 38. PMID 25924895 DOI: 10.1186/S12977-015-0164-6 |
0.52 |
|
| 2015 |
Olvera A, Pérez-Álvarez S, Ibarrondo J, Ganoza C, Lama JR, Lucchetti A, Cate S, Hildebrand W, Bernard N, Gomez L, Sanchez J, Brander C. The HLA-C*04: 01/KIR2DS4 gene combination and human leukocyte antigen alleles with high population frequency drive rate of HIV disease progression. Aids (London, England). 29: 507-17. PMID 25715101 DOI: 10.1097/Qad.0000000000000574 |
0.529 |
|
| 2015 |
Lisovsky I, Isitman G, Bruneau J, Bernard NF. Functional analysis of NK cell subsets activated by 721.221 and K562 HLA-null cells. Journal of Leukocyte Biology. 97: 761-7. PMID 25713086 DOI: 10.1189/Jlb.4Ab1014-499R |
0.358 |
|
| 2015 |
Tang CC, Isitman G, Bruneau J, Tremblay C, Bernard NF, Kent SJ, Parsons MS. Phenotypical and functional profiles of natural killer cells exhibiting matrix metalloproteinase-mediated CD16 cleavage after anti-HIV antibody-dependent activation. Clinical and Experimental Immunology. 181: 275-85. PMID 25644502 DOI: 10.1111/Cei.12593 |
0.567 |
|
| 2015 |
Veillette M, Coutu M, Richard J, Batraville LA, Dagher O, Bernard N, Tremblay C, Kaufmann DE, Roger M, Finzi A. The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals. Journal of Virology. 89: 545-51. PMID 25339767 DOI: 10.1128/Jvi.02868-14 |
0.595 |
|
| 2014 |
Tallon BJ, Bruneau J, Tsoukas CM, Routy JP, Kiani Z, Tan X, Bernard NF. Time to seroconversion in HIV-exposed subjects carrying protective versus non protective KIR3DS1/L1 and HLA-B genotypes. Plos One. 9: e110480. PMID 25330014 DOI: 10.1371/Journal.Pone.0110480 |
0.561 |
|
| 2014 |
Valiente-Echeverría F, Melnychuk L, Vyboh K, Ajamian L, Gallouzi IE, Bernard N, Mouland AJ. eEF2 and Ras-GAP SH3 domain-binding protein (G3BP1) modulate stress granule assembly during HIV-1 infection. Nature Communications. 5: 4819. PMID 25229650 DOI: 10.1038/Ncomms5819 |
0.479 |
|
| 2014 |
Richard J, Veillette M, Batraville LA, Coutu M, Chapleau JP, Bonsignori M, Bernard N, Tremblay C, Roger M, Kaufmann DE, Finzi A. Flow cytometry-based assay to study HIV-1 gp120 specific antibody-dependent cellular cytotoxicity responses. Journal of Virological Methods. 208: 107-14. PMID 25125129 DOI: 10.1016/J.Jviromet.2014.08.003 |
0.536 |
|
| 2014 |
Song R, Lisovsky I, Lebouché B, Routy JP, Bruneau J, Bernard NF. HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets. Plos Pathogens. 10: e1003867. PMID 24453969 DOI: 10.1371/Journal.Ppat.1003867 |
0.536 |
|
| 2013 |
Lisovsky I, Schader SM, Sloan RD, Oliveira M, Coutsinos D, Bernard NF, Wainberg MA. HIV-1 subtype variability in Vif derived from molecular clones affects APOBEC3G-mediated host restriction. Intervirology. 56: 258-64. PMID 23689841 DOI: 10.1159/000348513 |
0.494 |
|
| 2013 |
Parsons MS, Muller S, Kohler H, Grant MD, Bernard NF. On the benefits of sin: can greater understanding of the 1F7-idiotypic repertoire freeze enhance HIV vaccine development? Human Vaccines & Immunotherapeutics. 9: 1532-8. PMID 23571168 DOI: 10.4161/Hv.24460 |
0.441 |
|
| 2013 |
Parsons MS, Center RJ, Routy JP, Rouleau D, Leblanc R, Wainberg MA, Tremblay CL, Zannou MD, Kent SJ, Grant MD, Bernard NF. Short communication: antibody responses to human immunodeficiency virus envelope from infections with multiple subtypes utilize the 1F7-idiotypic repertoire. Aids Research and Human Retroviruses. 29: 778-83. PMID 23265432 DOI: 10.1089/Aid.2012.0094 |
0.479 |
|
| 2012 |
Doroudchi M, Yegorov O, Baumgartner T, Kernaleguen AE, Breton G, Ndongala ML, Boulassel MR, Routy JP, Bernard NF, Sékaly RP, Yassine-Diab B. Autologous HIV-1 clade-B Nef peptides elicit increased frequency, breadth and function of CD8+ T-cells compared to consensus peptides. Plos One. 7: e49562. PMID 23185362 DOI: 10.1371/Journal.Pone.0049562 |
0.501 |
|
| 2012 |
Peretz Y, He Z, Shi Y, Yassine-Diab B, Goulet JP, Bordi R, Filali-Mouhim A, Loubert JB, El-Far M, Dupuy FP, Boulassel MR, Tremblay C, Routy JP, Bernard N, Balderas R, et al. CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction. Plos Pathogens. 8: e1002840. PMID 22916009 DOI: 10.1371/Journal.Ppat.1002840 |
0.411 |
|
| 2012 |
Wren L, Parsons MS, Isitman G, Center RJ, Kelleher AD, Stratov I, Bernard NF, Kent SJ. Influence of cytokines on HIV-specific antibody-dependent cellular cytotoxicity activation profile of natural killer cells. Plos One. 7: e38580. PMID 22701674 DOI: 10.1371/Journal.Pone.0038580 |
0.583 |
|
| 2012 |
Wacleche VS, Chomont N, Gosselin A, Monteiro P, Goupil M, Kared H, Tremblay C, Bernard N, Boulassel MR, Routy JP, Ancuta P. The colocalization potential of HIV-specific CD8+ and CD4+ T-cells is mediated by integrin β7 but not CCR6 and regulated by retinoic acid. Plos One. 7: e32964. PMID 22470433 DOI: 10.1371/Journal.Pone.0032964 |
0.531 |
|
| 2012 |
Kamya P, Tallon B, Melendez-Pena C, Parsons MS, Migueles SA, Connors M, Miconiatis S, Song R, Boulet S, Bruneau J, Tremblay CL, Bernard NF. Inhibitory Killer Immunoglobulin-like Receptors to self HLA-B and HLA-C ligands contribute differentially to Natural Killer cell functional potential in HIV infected slow progressors. Clinical Immunology (Orlando, Fla.). 143: 246-55. PMID 22445844 DOI: 10.1016/J.Clim.2012.01.001 |
0.477 |
|
| 2012 |
Parsons MS, Wren L, Isitman G, Navis M, Stratov I, Bernard NF, Kent SJ. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity. Journal of Virology. 86: 4488-95. PMID 22345455 DOI: 10.1128/Jvi.06112-11 |
0.602 |
|
| 2012 |
Wang C, McPherson AJ, Jones RB, Kawamura KS, Lin GH, Lang PA, Ambagala T, Pellegrini M, Calzascia T, Aidarus N, Elford AR, Yue FY, Kremmer E, Kovacs CM, Benko E, ... ... Bernard NF, et al. Loss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infection. The Journal of Experimental Medicine. 209: 77-91. PMID 22184633 DOI: 10.1084/Jem.20110675 |
0.545 |
|
| 2012 |
Zanoni P, Tallon B, Miconiatis S, Shoukry N, Bruneau J, Tsoukas C, Bernard N. KIR/HLA genotype combinations are determinants of Natural Killer (NK) cell mediated antibody-dependent cellular cytotoxicity (ADCC) potency Retrovirology. 9: 187. DOI: 10.1186/1742-4690-9-S2-P187 |
0.541 |
|
| 2012 |
Tallon B, Bruneau J, Tsoukas C, Routy J, Bernard N. Are the KIR3DS1homozygous and KIR3DL1*h/*y+HLA-B*57 genotypes associated protection from HIV by different routes of exposure? Retrovirology. 9: 186. DOI: 10.1186/1742-4690-9-S2-P186 |
0.534 |
|
| 2012 |
Spaans JN, Routy JP, Tremblay C, Singer J, Bernard N, Gurunathan S, Sékaly RP, Angel JB. Optimizing the efficiency of therapeutic HIV vaccine trials: A case for CTN 173 Trials in Vaccinology. 1: 21-26. DOI: 10.1016/J.Trivac.2012.01.003 |
0.377 |
|
| 2012 |
Nazli A, Mueller K, Kim C, Kaul R, Bernard N, Kaushic C. Role of IL-22 in protecting mucosal barrier disruption by HIV-1 Journal of Reproductive Immunology. 94: 126-127. DOI: 10.1016/J.Jri.2012.03.480 |
0.442 |
|
| 2011 |
Kamya P, Tsoukas CM, Boulet S, Routy JP, Thomas R, Côté P, Boulassel MR, Lessard B, Kaul R, Ostrowski M, Kovacs C, Tremblay CL, Bernard NF. T cell Activation does not drive CD4 decline in longitudinally followed HIV-infected Elite Controllers. Aids Research and Therapy. 8: 20. PMID 21679427 DOI: 10.1186/1742-6405-8-20 |
0.538 |
|
| 2011 |
Peretz Y, Marra O, Thomas R, Legault D, Côté P, Boulassel MR, Rouleau D, Routy JP, Sékaly RP, Tsoukas CM, Tremblay C, Bernard NF. Relative contribution of HIV-specific functional lymphocyte subsets restricted by protective and non-protective HLA alleles. Viral Immunology. 24: 189-98. PMID 21668360 DOI: 10.1089/Vim.2010.0117 |
0.47 |
|
| 2011 |
Parsons MS, Rouleau D, Routy JP, LeBlanc R, Grant MD, Bernard NF. Selection of human anti-HIV broadly neutralizing antibodies occurs within the context of frozen 1F7-idiotypic repertoire. Aids (London, England). 25: 1249-64. PMID 21516028 DOI: 10.1097/Qad.0B013E328347F9Fa |
0.503 |
|
| 2011 |
Kamya P, Boulet S, Tsoukas CM, Routy JP, Thomas R, Côté P, Boulassel MR, Baril JG, Kovacs C, Migueles SA, Connors M, Suscovich TJ, Brander C, Tremblay CL, Bernard N, et al. Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1*h/*y and HLA-B*57. Journal of Virology. 85: 5949-60. PMID 21471235 DOI: 10.1128/Jvi.02652-10 |
0.431 |
|
| 2011 |
Angel JB, Routy JP, Tremblay C, Ayers D, Woods R, Singer J, Bernard N, Kovacs C, Smaill F, Gurunathan S, Sekaly RP. A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune. Aids (London, England). 25: 731-9. PMID 21330911 DOI: 10.1097/Qad.0B013E328344Cea5 |
0.522 |
|
| 2010 |
Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, Kadie CM, Carlson JM, Heckerman D, Graham RR, ... ... Bernard NF, et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (New York, N.Y.). 330: 1551-7. PMID 21051598 DOI: 10.1126/Science.1195271 |
0.443 |
|
| 2010 |
Parsons MS, Boulet S, Song R, Bruneau J, Shoukry NH, Routy JP, Tsoukas CM, Bernard NF. Mind the gap: lack of association between KIR3DL1*004/HLA‐Bw4-induced natural killer cell function and protection from HIV infection. The Journal of Infectious Diseases. 202: S356-60. PMID 20887224 DOI: 10.1086/655966 |
0.528 |
|
| 2010 |
Ndongala ML, Kamya P, Boulet S, Peretz Y, Rouleau D, Tremblay C, Leblanc R, Côté P, Baril JG, Thomas R, Vézina S, Boulassel MR, Routy JP, Sékaly RP, Bernard NF. Changes in function of HIV-specific T-cell responses with increasing time from infection. Viral Immunology. 23: 159-68. PMID 20373996 DOI: 10.1089/Vim.2009.0084 |
0.555 |
|
| 2010 |
Boulet S, Ndongala ML, Bernard NF. Dual-color ELISPOT assay for the simultaneous detection of IL-2 and/or IFN-gamma secreting T cells. Cold Spring Harbor Protocols. 2010: pdb.prot5369. PMID 20150128 DOI: 10.1101/Pdb.Prot5369 |
0.4 |
|
| 2010 |
Boulet S, Song R, Kamya P, Bruneau J, Shoukry NH, Tsoukas CM, Bernard NF. HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 2057-64. PMID 20061407 DOI: 10.4049/Jimmunol.0902621 |
0.534 |
|
| 2009 |
Huang KH, Loutfy MR, Boulet S, Toma E, Tsoukas CM, Bernard NF. Predictive value of immune parameters before treatment interruption (TI) for CD4+ T-cell count change during TI in HIV infection. Antiviral Therapy. 14: 381-92. PMID 19474472 |
0.417 |
|
| 2009 |
Ndongala ML, Peretz Y, Boulet S, Doroudchi M, Yassine-Diab B, Boulassel MR, Rouleau D, Tremblay C, LeBlanc R, Routy JP, Sékaly RP, Bernard NF. HIV Gag p24 specific responses secreting IFN-gamma and/or IL-2 in treatment-naïve individuals in acute infection early disease (AIED) are associated with low viral load. Clinical Immunology (Orlando, Fla.). 131: 277-87. PMID 19135418 DOI: 10.1016/J.Clim.2008.11.006 |
0.527 |
|
| 2009 |
Kamya P, Boulet S, Tremblay C, Bernard N. T.12. Functional Potential of NK Cells from HIV Infected Slow Progressors Differs According to KIR/HLA Genotype Clinical Immunology. 131: S51. DOI: 10.1016/J.Clim.2009.03.145 |
0.559 |
|
| 2008 |
Boulet S, Bernard NF. [Carrying certain KIR3DL1 alleles with HLA-B*57 is associated with protection from HIV infection]. MéDecine Sciences : M/S. 24: 1030-2. PMID 19116110 DOI: 10.1051/Medsci/200824121030 |
0.519 |
|
| 2008 |
Boulet S, Kleyman M, Kim JY, Kamya P, Sharafi S, Simic N, Bruneau J, Routy JP, Tsoukas CM, Bernard NF. A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection. Aids (London, England). 22: 1487-91. PMID 18614872 DOI: 10.1097/Qad.0B013E3282Ffde7E |
0.431 |
|
| 2008 |
Peretz Y, Tsoukas CM, Bernard NF. HIV Gag-specific immune responses predict the rate of CD4 decline. Aids (London, England). 22: 1222-4. PMID 18525269 DOI: 10.1097/Qad.0B013E3283021A76 |
0.46 |
|
| 2008 |
Huang KH, Loutfy MR, Tsoukas CM, Bernard NF. Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption. Bmc Infectious Diseases. 8: 59. PMID 18454861 DOI: 10.1186/1471-2334-8-59 |
0.482 |
|
| 2008 |
Boulet S, Sharafi S, Simic N, Bruneau J, Routy JP, Tsoukas CM, Bernard NF. Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. Aids (London, England). 22: 595-9. PMID 18317000 DOI: 10.1097/Qad.0B013E3282F56B23 |
0.567 |
|
| 2008 |
Boulet S, Kleyman M, Kamya P, Kim J, Sharafi S, Simic N, Bruneau J, Routy J, Tsoukas C, Bernard N. Su.6. KIR3DS/L1 Alleles and Reduced Risk of HIV Infection in Exposed Persistently Seronegative Subjects Clinical Immunology. 127: S126. DOI: 10.1016/J.Clim.2008.03.357 |
0.477 |
|
| 2007 |
Wang C, Wen T, Routy JP, Bernard NF, Sekaly RP, Watts TH. 4-1BBL induces TNF receptor-associated factor 1-dependent Bim modulation in human T cells and is a critical component in the costimulation-dependent rescue of functionally impaired HIV-specific CD8 T cells. Journal of Immunology (Baltimore, Md. : 1950). 179: 8252-63. PMID 18056369 DOI: 10.4049/Jimmunol.179.12.8252 |
0.479 |
|
| 2007 |
Peretz Y, Ndongala ML, Boulet S, Boulassel MR, Rouleau D, Côté P, Longpré D, Routy JP, Falutz J, Tremblay C, Tsoukas CM, Sékaly RP, Bernard NF. Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: correlation of these functional T cell subsets with markers of disease progression. Clinical Immunology (Orlando, Fla.). 124: 57-68. PMID 17521962 DOI: 10.1016/J.Clim.2007.04.004 |
0.507 |
|
| 2007 |
Rosenthal E, Pialoux G, Bernard N, Pradier C, Rey D, Bentata M, Michelet C, Pol S, Perronne C, Cacoub P. Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study). Journal of Viral Hepatitis. 14: 183-188. PMID 17305884 DOI: 10.1111/J.1365-2893.2006.00791.X |
0.435 |
|
| 2007 |
Boulet S, Ndongala ML, Peretz Y, Boisvert MP, Boulassel MR, Tremblay C, Routy JP, Sekaly RP, Bernard NF. A dual color ELISPOT method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses. Journal of Immunological Methods. 320: 18-29. PMID 17222422 DOI: 10.1016/J.Jim.2006.11.010 |
0.536 |
|
| 2006 |
Huang KH, Boisvert MP, Chung F, Loignon M, Zarowny D, Cyr L, Toma E, Bernard NF. Longitudinal changes in HIV-specific IFN-gamma secretion in subjects who received Remune vaccination prior to treatment interruption. Journal of Immune Based Therapies and Vaccines. 4: 7. PMID 17132168 DOI: 10.1186/1476-8518-4-7 |
0.519 |
|
| 2006 |
Valcke HS, Bernard NF, Bruneau J, Alary M, Tsoukas CM, Roger M. APOBEC3G genetic variants and their association with risk of HIV infection in highly exposed Caucasians. Aids (London, England). 20: 1984-6. PMID 16988524 DOI: 10.1097/01.Aids.0000247124.35129.E1 |
0.515 |
|
| 2005 |
Bukczynski J, Wen T, Wang C, Christie N, Routy JP, Boulassel MR, Kovacs CM, Macdonald KS, Ostrowski M, Sekaly RP, Bernard NF, Watts TH. Enhancement of HIV-specific CD8 T cell responses by dual costimulation with CD80 and CD137L. Journal of Immunology (Baltimore, Md. : 1950). 175: 6378-89. PMID 16272290 DOI: 10.4049/Jimmunol.175.10.6378 |
0.527 |
|
| 2005 |
Serghides L, Bukczynski J, Wen T, Wang C, Routy JP, Boulassel MR, Sekaly RP, Ostrowski M, Bernard NF, Watts TH. Evaluation of OX40 ligand as a costimulator of human antiviral memory CD8 T cell responses: comparison with B7.1 and 4-1BBL. Journal of Immunology (Baltimore, Md. : 1950). 175: 6368-77. PMID 16272289 DOI: 10.4049/Jimmunol.175.10.6368 |
0.386 |
|
| 2005 |
Troesch M, Jalbert E, Canobio S, Boulassel MR, Routy JP, Bernard NF, Bruneau J, Lapointe N, Boucher M, Soudeyns H. Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV-1. Aids (London, England). 19: 775-84. PMID 15867491 DOI: 10.1097/01.Aids.0000168971.57681.6E |
0.405 |
|
| 2005 |
Peretz Y, Alter G, Boisvert MP, Hatzakis G, Tsoukas CM, Bernard NF. Human immunodeficiency virus (HIV)-specific gamma interferon secretion directed against all expressed HIV genes: relationship to rate of CD4 decline. Journal of Virology. 79: 4908-17. PMID 15795276 DOI: 10.1128/Jvi.79.8.4908-4917.2005 |
0.668 |
|
| 2005 |
Makedonas G, Bruneau J, Alary M, Tsoukas CM, Lowndes CM, Lamothe F, Bernard NF. Comparison of HIV-specific CD8 T-cell responses among uninfected individuals exposed to HIV parenterally and mucosally. Aids (London, England). 19: 251-9. PMID 15718835 |
0.491 |
|
| 2004 |
Alter G, Tsoukas CM, Rouleau D, Côté P, Routy JP, Sékaly RP, Bernard NF. Assessment of longitudinal changes in HIV-specific effector activity in subjects undergoing untreated primary HIV infection. Aids (London, England). 18: 1979-89. PMID 15577619 DOI: 10.1097/00002030-200410210-00002 |
0.678 |
|
| 2003 |
Alter G, Hatzakis G, Tsoukas CM, Pelley K, Rouleau D, LeBlanc R, Baril JG, Dion H, Lefebvre E, Thomas R, Côté P, Lapointe N, Routy JP, Sékaly RP, Conway B, ... Bernard NF, et al. Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection. Journal of Immunology (Baltimore, Md. : 1950). 171: 477-88. PMID 12817033 DOI: 10.4049/Jimmunol.171.1.477 |
0.682 |
|
| 2002 |
Ifergan I, Bernard NF, Bruneau J, Alary M, Tsoukas CM, Roger M. Allele frequency of three functionally active polymorphisms of the MDR-1 gene in high-risk HIV-negative and HIV-positive Caucasians. Aids (London, England). 16: 2340-2. PMID 12441809 DOI: 10.1097/00002030-200211220-00017 |
0.55 |
|
| 2002 |
Makedonas G, Bruneau J, Lin H, Sékaly RP, Lamothe F, Bernard NF. HIV-specific CD8 T-cell activity in uninfected injection drug users is associated with maintenance of seronegativity. Aids (London, England). 16: 1595-602. PMID 12172080 DOI: 10.1097/00002030-200208160-00004 |
0.568 |
|
| 2002 |
Alter G, Merchant A, Tsoukas CM, Rouleau D, LeBlanc RP, Côté P, Baril JG, Thomas R, Nguyen VK, Sékaly RP, Routy JP, Bernard NF. Human immunodeficiency virus (HIV)-specific effector CD8 T cell activity in patients with primary HIV infection. The Journal of Infectious Diseases. 185: 755-65. PMID 11920293 DOI: 10.1086/339338 |
0.68 |
|
| 2001 |
Tsoukas CM, Walmsley SL, Bernard NF, Turner HM, Hatzakis GE, Blake GP, Goodhew JE, Kilby DLP, Kovacs CM, Luetkehoelter JR, Routy JP. Improvement of HIV-specific immunity in HIV-infected twins treated with highly active antiretroviral therapy, interleukin 2, and syngeneic adoptively transferred cells Aids Research and Human Retroviruses. 17: 887-900. PMID 11461675 DOI: 10.1089/088922201750290014 |
0.588 |
|
| 1999 |
Bernard NF, Yannakis CM, Jimmy S L, Tsoukas CM. Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons Journal of Infectious Diseases. 179: 538-547. PMID 9952359 DOI: 10.1086/314621 |
0.563 |
|
| 1998 |
Bernard NF, Chernoff DN, Tsoukas CM. Effect of splenectomy on T-cell subsets and plasma HIV viral titers in HIV-infected patients Journal of Human Virology. 1: 338-345. PMID 10195261 |
0.507 |
|
| 1998 |
Bernard NF, Pederson K, Chung F, Ouellet L, Wainberg MA, Tsoukas CM. HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected persons Aids. 12: 2125-2139. PMID 9833853 DOI: 10.1097/00002030-199816000-00007 |
0.612 |
|
| 1998 |
Tsoukas CM, Raboud J, Bernard NF, Montaner JS, Gill MJ, Rachlis A, Fong IW, Schlech W, Djurdjev O, Freedman J, Thomas R, Lafrenière R, Wainberg MA, Cassol S, O'Shaughnessy M, et al. Active immunization of patients with HIV infection: a study of the effect of VaxSyn, a recombinant HIV envelope subunit vaccine, on progression of immunodeficiency. Aids Research and Human Retroviruses. 14: 483-90. PMID 9566550 DOI: 10.1089/Aid.1998.14.483 |
0.59 |
|
| 1998 |
Tsoukas CM, Bernard NF, Abrahamowicz M, Strawczynski H, Growe G, Card RT, Gold P. Effect of splenectomy on slowing human immunodeficiency virus disease progression Archives of Surgery. 133: 25-31. PMID 9438754 DOI: 10.1001/Archsurg.133.1.25 |
0.534 |
|
| 1994 |
Tsoukas CM, Bernard NF. Markers predicting progression of human immunodeficiency virus-related disease Clinical Microbiology Reviews. 7: 14-28. PMID 8118788 DOI: 10.1128/Cmr.7.1.14 |
0.515 |
|
| 1994 |
Margolese H, O'Keefe C, Chung F, Ertug F, Wall JR, Bernard NF. Expression of major histocompatibility complex class II antigen in NOD mouse thyroid. Autoimmunity. 17: 1-11. PMID 8025210 DOI: 10.3109/08916939409014653 |
0.305 |
|
| 1994 |
Wall JR, Triller H, Chung F, Tsao M, Boucher A, Rodien P, Liberman A, Bernard N. Cross-reactive antibodies in the serum of balb/c mice immunized with thyroid or eye muscle membranes. Journal of Endocrinological Investigation. 17: 105-12. PMID 7516357 DOI: 10.1007/Bf03347694 |
0.31 |
|
| 1993 |
Wall JR, Bernard N, Boucher A, Salvi M, Zhang ZG, Kennerdell J, Tyutyunikov A, Genovese C. Pathogenesis of Thyroid-Associated Ophthalmopathy: An Autoimmune Disorder of the Eye Muscle Associated with Graves' Hyperthyroidism and Hashimoto's Thyroiditis Clinical Immunology and Immunopathology. 68: 1-8. PMID 8513588 DOI: 10.1006/Clin.1993.1087 |
0.304 |
|
| 1993 |
Wall JR, Triller H, Boucher A, Bernard NF, Salvi M, Ludgate M. Antibodies reactive with an intracellular epitope of a recombinant 64 kDa thyroid and eye muscle protein in patients with thyroid autoimmunity and ophthalmopathy Journal of Endocrinological Investigation. 16: 863-868. PMID 7511621 DOI: 10.1007/Bf03348946 |
0.303 |
|
| 1992 |
Salvi M, Bernard N, Miller A, Zhang ZG, Gardini E, Wall JR. Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy. Thyroid : Official Journal of the American Thyroid Association. 1: 207-13. PMID 1824337 DOI: 10.1089/Thy.1991.1.207 |
0.324 |
|
| 1992 |
Zhang ZG, Salvi M, Miller A, Bernard N, Arthurs B, Wall JR. Restricted tissue reactivity of autoantibodies to a 64-kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy. Clinical Immunology and Immunopathology. 62: 183-9. PMID 1730156 DOI: 10.1016/0090-1229(92)90071-U |
0.332 |
|
| 1992 |
Cohen M, Salvi M, Miller A, Bernard N, Wall JR. Cell-mediated immunity to orbital tissue antigens in thyroid-associated ophthalmopathy determined using the leukocyte procoagulant activity assay. Autoimmunity. 11: 225-31. PMID 1581466 DOI: 10.3109/08916939209035159 |
0.336 |
|
| 1991 |
Fukazawa H, Hiromatsu Y, Bernard N, Salvi M, Wall JR. Binding of peripheral blood and thyroidal T lymphocytes to thyroid cell monolayers: possible role of "homing-like" receptors in the pathogenesis of thyroid autoimmunity. Autoimmunity. 10: 181-188. PMID 1756223 DOI: 10.3109/08916939109001888 |
0.321 |
|
| 1991 |
Bernard NF, Ertug F, Teboul N, Zhang ZG, Salvi M, Wall JR. Isotype and immunoglobulin subclass distribution of Eye muscle membrane reactive antibodies in the serum of patients with thyroid-associated ophthalmopathy as detected in western blotting Autoimmunity. 10: 57-63. PMID 1742423 DOI: 10.3109/08916939108997148 |
0.309 |
|
| 1990 |
Kapusta M, Salvi M, Triller H, Gardini E, Bernard N, Wall JR. Eye muscle membrane reactive antibodies are not detected in the serum or immunoglobulin fraction of patients with thyroid-associated ophthalmopathy using an ELISA and crude membranes. Autoimmunity. 7: 33-40. PMID 2103308 DOI: 10.3109/08916939009041048 |
0.308 |
|
| 1988 |
Salvi M, Fukazawa H, Bernard N, Hiromatsu Y, How J, Wall JR. Role of Autoantibodies in the Pathogenesis and Association of Endocrine Autoimmune Disorders Endocrine Reviews. 9: 450-466. PMID 3065074 DOI: 10.1210/Edrv-9-4-450 |
0.301 |
|
| Show low-probability matches. |